Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and ...

Simon Fraser University Researchers are using an advanced brain imaging method called MEG to understand why Parkinson's drug levodopa doesn't work equally well for everyone. By mapping patients' brain ...

The 250-bed hospital, inaugurated in 2008 and spread over 8.82 acres, caters to a large population in west Delhi and depends ...

Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used ...

Background A 48-year-old man with a 9-year history of Parkinson's disease who had previously shown a good response to levodopa presented for evaluation of increasingly disabling motor fluctuations ...

Five-year View Very long acting (> 6–8 h) levodopa preparations are still likely to represent the next chapter in the medical treatment of PD. Continuous-infusion levodopa gel, long-acting ...

Abstract Abstract Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an analysis of RHHBY stock now.

Fintel reports that on July 1, 2025, Cantor Fitzgerald initiated coverage of Trevi Therapeutics (NasdaqGM:TRVI) with a ...